COMPANY
APOTEX INC
APOTEX INC: marketing authorisation holder for Calcitonin, Desmopressin, Semaglutide, Teriparatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Calcitonin | APO-CALCITONIN INJECTABLE (DIN 02246058), Cancelled Post Market Regulator Health Canada |
|---|---|
| Calcitonin | APO-CALCITONIN NASAL SPRAY (DIN 02247585), Cancelled Post Market Regulator Health Canada |
| Desmopressin | APO-DESMOPRESSIN (DIN 02284030), Marketed Regulator Health Canada |
| Desmopressin | APO-DESMOPRESSIN (DIN 02284049), Marketed Regulator Health Canada |
| Semaglutide | APO-SEMAGLUTIDE INJECTION (DIN 02568012), Marketed Regulator Health Canada |
| Semaglutide | APO-SEMAGLUTIDE INJECTION (DIN 02568020), Marketed Regulator Health Canada |
| Semaglutide | SEVMIA (DIN 02569582), Approved Regulator Health Canada |
| Teriparatide | APO-TERIPARATIDE INJECTION (DIN 02498804), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.